Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws

March 8, 2023 updated by: St. Olavs Hospital

A Prospective Randomized Controlled Trial Comparing the Endobutton CL BTB Fixation System With Metal Interference Screws in the Femoral Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction.

In this randomized controlled trial the investigators will compare the results after primary anterior cruciate ligament (ACL) reconstruction using two different methods for femoral fixation of a bone-patellar tendon-bone (BPTB) autograft. Interference screws have been the standard method for fixing the femoral side of BPTB grafts; however, several pitfalls have been reported. Cortical fixation with the Endobutton CL BTB Fixation System has become available and the clinical results have been described as promising; however, no randomized controlled trials comparing these two femoral fixation methods have been conducted, and there is no published data that confirms that the bone block heals in the tunnel with the newer method.

The aim of our study is to compare the outcome after primary ACL reconstruction with BPTB autografts using the Endobutton CL BTB or metal interference screw for femoral fixation.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Primary anterior cruciate ligament (ACL) reconstructions with bone-patellar tendon-bone (BPTB) autografts have recently been found to have a lower risk of revision compared with hamstring tendon autografts, and BPTB has again become our graft of choice. Interference screws have been the standard method for fixing the femoral side of a BPTB graft; however problems such as damage of the graft and failure due to nonparallel screw placement have been reported. Cortical fixation using a suspensory system has been used for soft-tissue graft fixation for several years, and a corresponding device, the Endobutton CL BTB Fixation System (Smith & Nephew, Inc., Andover, MA, USA), has become available for fixation of bone-tendon-bone grafts. The clinical results after fixation with the Endobutton CL BTB have been described as promising; however, no randomized controlled trials comparing these two fixation methods have been conducted, and there is no published data that confirms that the bone block heals in the tunnel with the newer method.

In this randomized controlled trial, patients undergoing primary ACL reconstruction will be randomized into either an Endobutton group or an interference screw group. The primary aim of the study is to compare these two fixation methods, assessed by patient reported outcomes, laxity, range of motion and muscle strength. Knee related quality of life 2 years after surgery is the primary outcome, measured by the Knee injury and Osteoarthritis Outcome Score (KOOS) subscale "knee related Quality of life (QOL)". Other aims are to see if there is any difference in the integration of the bone block in the femoral tunnel assessed by CT scan, in the risk of developing osteoarthritis assessed by radiographs, or in the risk of a postoperative complication or revision. The patients will be followed up 6 weeks, 6 months, 2 years and 10 years after surgery. CT scan will be performed after 6 months, and radiographs after 2 years and 10 years. In addition details of the rehabilitation will be recorded. Patients undergoing a revision will be followed up but excluded from further comparisons in the study.

Our hypothesis is that there is no difference in the outcome after primary ACL reconstruction with BPTB autografts using the Endobutton CL BTB or metal interference screw for femoral fixation, both with a metal interference screw for the tibial fixation.

Study Type

Interventional

Enrollment (Anticipated)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Trondheim, Norway
        • Recruiting
        • Department of Orthopedic Surgery, St Olavs Hospital
      • Trondheim, Norway
        • Recruiting
        • Rosenborgklinikken
        • Contact:
          • Agnar Tegnander, md phd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary reconstruction of ACL ruptures
  • Surgery at least 6 weeks after injury
  • The patient must accept and sign the informed consent form before surgery

Exclusion Criteria:

  • Medical indication for using another graft than BPTB autograft (such as history of anterior knee pain or occupations etc. requiring frequent kneeling)
  • Previous major surgical procedures in the same knee
  • Major additional injuries in the knee (posterior cruciate ligament, lateral collateral ligament, medial collateral ligament, sutured meniscus lesions and major cartilage lesions undergoing cartilage repair)
  • Contralateral ACL injury (treated or untreated)
  • Present or former serious illness that makes follow-up or rehabilitation difficult (e.g. alcohol or drug abuse, psychiatric disease)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Endobutton CL BTB
Femoral fixation of the BPTB autograft with the Endobutton CL BTB Fixation System.
ACL reconstruction with Endobutton CL BTB
Active Comparator: Metal interference screw
Femoral fixation of the BPTB autograft with a metal interference screw.
ACL reconstruction with metal interference screw

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee related quality of life
Time Frame: 2 years
KOOS subscale "knee related Quality of life (QOL)"
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tegner activity scale
Time Frame: 6 months, 2 years, 10 years
6 months, 2 years, 10 years
Lachman test
Time Frame: 6 weeks, 6 months, 2 years, 10 years
Anterior translation of the tibia
6 weeks, 6 months, 2 years, 10 years
Muscular strength
Time Frame: 6 months, 2 years, 10 years
Biodex dynamometer
6 months, 2 years, 10 years
Bone block integration
Time Frame: 6 months
CT scan
6 months
Osteoarthritis
Time Frame: 2 years, 10 years
X-ray radiographs
2 years, 10 years
Range of motion
Time Frame: 6 weeks, 6 months, 2 years, 10 years
6 weeks, 6 months, 2 years, 10 years
Knee related quality of life
Time Frame: 6 weeks
KOOS subscale "knee related Quality of life (QOL)"
6 weeks
Knee related quality of life
Time Frame: 6 months
KOOS subscale "knee related Quality of life (QOL)"
6 months
Knee related quality of life
Time Frame: 10 years
KOOS subscale "knee related Quality of life (QOL)"
10 years
Lysholm functional knee score
Time Frame: 6 weeks, 6 months, 2 years, 10 years
6 weeks, 6 months, 2 years, 10 years
KOOS
Time Frame: 6 weeks, 6 months, 2 years, 10 years
Knee injury and Osteoarthritis Outcome Score
6 weeks, 6 months, 2 years, 10 years
Pivot shift test
Time Frame: 6 weeks, 6 months, 2 years, 10 years
Anteroposterior and rotational stability
6 weeks, 6 months, 2 years, 10 years
KT-1000 arthrometer
Time Frame: 6 weeks, 6 months, 2 years, 10 years
Anterior translation of the tibia
6 weeks, 6 months, 2 years, 10 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: Up to 10 years
Registration
Up to 10 years
Reoperations
Time Frame: Up to 10 years
Registration
Up to 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jon Olav Drogset, md phd, St. Olavs Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Anticipated)

March 1, 2025

Study Completion (Anticipated)

March 1, 2033

Study Registration Dates

First Submitted

June 20, 2016

First Submitted That Met QC Criteria

September 27, 2016

First Posted (Estimate)

September 29, 2016

Study Record Updates

Last Update Posted (Estimate)

March 9, 2023

Last Update Submitted That Met QC Criteria

March 8, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2015/993

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Endobutton CL BTB

3
Subscribe